ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1864

Swimming Is As Effective As Walking for Treating Fibromyalgia: A Randomized Controlled Trial

Giovana Fernandes, Fabio Jennings, Michele V. Nery, Ana Leticia P. de Buosi and Jamil Natour, Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Exercise and fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibromyalgia (FM) is a chronic widespread pain syndrome that causes deterioration of physical capacity.  Exercises are fundamental in the treatment of FM and walking is the most common aerobic exercise studied. However, it is not known the effects of swimming in patients with FM. The purpose of this study was to evaluate the effects of swimming on pain, functional capacity, health-related quality of life, general quality of life and aerobic capacity in patients with FM, compared to walking.

Methods: Seventy-five women with diagnosis of FM according to ACR criteria with age between 18 and 60 years were selected. The patients were randomized to swimming group (SG) or walking group (WG). The SG performed swimming in front-crawl style and the heart rate (HR) training was defined by subtracting 10 beats from anaerobic threshold heart rate to compensate underwater horizontal position. The WG performed walking at anaerobic threshold HR. Exercise sessions had duration of 50 minutes and were performed three times a week for 12 weeks. The outcome measures were visual analogue scale (VAS) for pain, Time Up and Go Test (TUG) for functional capacity, Fibromyalgia Impact Questionnaire (FIQ) for health-related quality of life and SF 36 for general quality of life. Aerobic capacity was measured by an incremental cardiopulmonary exercise testing protocol by treadmill.  The evaluations were done by a blinded assessor at baseline (T0), 6 (T6) and 12 weeks (T12) after randomization. It was used intention-to-treat analysis.

Results: Thirty-nine patients were randomized to SG and 36 to WG. The groups were homogeneous at baseline regarding clinical and demographic characteristics.  Five patients (3 in SG and 2 in WG) withdrew after few exercise sessions because of pain worsening. After 12 weeks, both groups improved pain, functional capacity and quality of life (FIQ and SF 36) compared to baseline, however there were no differences between groups. Regarding aerobic capacity, both groups did not show changes over time. Tolerance to exercise, measured by adherence to programs, was similar in both groups (77.8% in SG and 72.2% in WG).

Conclusion: Swimming is as effective as walking in improving pain, functional capacity, health-related quality of life and general quality of life in patients with FM. In addition, swimming is well-tolerated by patients with FM. However, clinical improvements are not associated to aerobic capacity. More studies are necessary to define the mechanisms by with aerobic exercises lead to symptom improvements in FM.


Disclosure:

G. Fernandes,
None;

F. Jennings,
None;

M. V. Nery,
None;

A. L. P. de Buosi,
None;

J. Natour,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/swimming-is-as-effective-as-walking-for-treating-fibromyalgia-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology